Approval · Notice of Compliance 1631 · 2004
FLOXIN: Notice of Compliance 1631
Issued April 15, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1631
- Date
- April 15, 2004
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Removal of indication: for uncomplicated cystitis and complicated urinary tract infections
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLOXIN | Not yet assigned | — |